ClinicalTrials.Veeva

Menu

Morphological Changes of the Brain by MRI in Chronic Kidney Disease (KIDBRAIN)

H

Hospital General Universitario Gregorio Marañon

Status

Unknown

Conditions

Chronic Kidney Disease Requiring Chronic Dialysis

Treatments

Device: MRI

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to describe brain´s morphological changes induced by chronic kidney disease (CKD) in advanced stages (stages 4 and 5 defined by KDOQI guidelines) and also by haemodialysis using MRI.

Based on the hypothesis that hypotension may cause damage in some organs including brain the investigators study if intradialytic hypotension (IDH) causes any type of changes in gray and white matter of the brain.

Full description

There will be two groups: one in haemodialysis treatment and the other with chronic kidney disease patients in advanced stages (stages 4 and 5 defined by KDOQI guidelines).

Both groups will be evaluated with a MRI without contrast. A second MRI to identify brain´s morphological changes will be performed in patients of the first group a year later and in patients of the second group that will have been begun haemodialysis six months after.

In a first transverse evaluation, eighteen haemodialysis sessions from the first group will be studied with a retrospective analysis. The first three sessions of each month for six months before the MRI will be considered.

In each session the investigators will collect haemodynamic variables (systolic arterial blood pressure pre and post dialysis), intradialytic hypotension based on different definitions (Nadir90, Nadir100, Fall20, Fall30) and proper haemodialysis variables (KtV, convective transport).

In the first group and patients with CKD that will start haemodialysis, the investigators analyse the variables considered in the transverse evaluation until complete one year follow up.

Statistical analysis will be done with SPSS version 20.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Prevalent patients of haemodialysis (6 months minimum)
  • Patients with CKD (stages 4 and 5)
  • Informed consent signed

Exclusion criteria

  • Refusion to participate in the study
  • Presence of contraindications for MRI
  • Presence of clinic neurologic disorders

Trial design

100 participants in 2 patient groups

Predialysis
Description:
Patients with CKD (4 and 5 stages by KDOQI guidelines) underwent MRI to obtain in vivo images of brain anatomy that were subsequently analyzed by the data processing package FreeSurfer (version 5.3). A MRI 6 months after starting haemodialysis will be performed to analyze changes in gray and white matter of the brain.
Treatment:
Device: MRI
Haemodialysis
Description:
Patients with end stage of renal disease (ESRD) in haemodialysis underwent MRI to obtain in vivo images of brain anatomy that were subsequently analyzed by the data processing package FreeSurfer (version 5.3). A one year follow up MRI will be performed to analyze the changes in gray and white matter of the brain.
Treatment:
Device: MRI

Trial contacts and locations

1

Loading...

Central trial contact

Santiago Cedeño Mora, MD; Juan M. López Gómez, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems